205 related articles for article (PubMed ID: 19361026)
1. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study.
Runge M; Møller CH; Steinbrüchel DA
J Extra Corpor Technol; 2009 Mar; 41(1):10-4. PubMed ID: 19361026
[TBL] [Abstract][Full Text] [Related]
2. The Hemochron Response RxDx heparin and protamine dosing system.
Jaryno SA; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
[TBL] [Abstract][Full Text] [Related]
3. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
El Rouby S; Rinehart K; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
[TBL] [Abstract][Full Text] [Related]
4. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
Shore-Lesserson L; Reich DL; DePerio M
Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
[TBL] [Abstract][Full Text] [Related]
5. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
[TBL] [Abstract][Full Text] [Related]
6. A four-year experience with patient individualized heparin and protamine dosing using the Hemochron RxDx system.
Bennett KM; Briggins D; Zucker M; LaDuca F
J Extra Corpor Technol; 2001 Feb; 33(1):19-22. PubMed ID: 11315128
[TBL] [Abstract][Full Text] [Related]
7. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
Peterson JA; Maroney SA; Zwifelhofer W; Wood JP; Yan K; Bercovitz RS; Woods RK; Mast AE
J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
[TBL] [Abstract][Full Text] [Related]
8. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
9. Protamine dosage based on two titrations reduces blood loss after valve replacement surgery: a prospective, double-blinded, randomized study.
Guo Y; Tang J; Du L; Liu J; Liu RC; Liu X; Guo Y
Can J Cardiol; 2012; 28(5):547-52. PubMed ID: 22633184
[TBL] [Abstract][Full Text] [Related]
10. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F
PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705
[TBL] [Abstract][Full Text] [Related]
11. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
[TBL] [Abstract][Full Text] [Related]
12. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass.
Shigeta O; Kojima H; Hiramatsu Y; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):354-60. PubMed ID: 10425010
[TBL] [Abstract][Full Text] [Related]
13. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
14. Heparin reversal in off-pump coronary artery bypass surgery: complete, partial, or no reversal?
Gatti G; Pugliese P
Cardiovasc Surg; 2002 Jun; 10(3):245-50. PubMed ID: 12044433
[TBL] [Abstract][Full Text] [Related]
15. Activated platelet aggregation is transiently impaired also by a reduced dose of protamine.
Olsson A; Alfredsson J; Thelander M; Svedjeholm R; Berglund JS; Berg S
Scand Cardiovasc J; 2019 Dec; 53(6):355-360. PubMed ID: 31476919
[No Abstract] [Full Text] [Related]
16. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S
Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
[TBL] [Abstract][Full Text] [Related]
17. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
Levin AI; Heine AM; Coetzee JF; Coetzee A
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
[TBL] [Abstract][Full Text] [Related]
18. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
[TBL] [Abstract][Full Text] [Related]
19. Calculation Algorithm Reduces Protamine Doses Without Increasing Blood Loss or the Transfusion Rate in Cardiac Surgery: Results of a Randomized Controlled Trial.
Kjellberg G; Holm M; Fux T; Lindvall G; van der Linden J
J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):985-992. PubMed ID: 30206011
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of coronary artery bypass surgery performed with the Resting Heart™ System utilizing a low vs a standard dosage of heparin.
Nilsson J; Scicluna S; Malmkvist G; Pierre L; Algotsson L; Paulsson P; Bjursten H; Johnsson P
Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):834-9. PubMed ID: 22914806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
